glp 1 agonist overdose GLP-1 receptor agonists show promise in treating substance use disorders GLP-1 and Anesthesia: Considerations and
Description
The primary outcome was the incremental cost-effectiveness ratio (ICER), defined as cost per QALY gained, with the willingness-to-pay threshold set at AU$28,000 per QALY [15]
Certain medical conditions and safety concerns make these medications unsafe or not recommended for some people
We also assess the potential mechanisms that contribute to the reduction in major adverse cardiovascular events in individuals treated with GLP1R agonists and highlight the emerging cardiovascular biology of novel GLP1-based multi-agonists currently in development
[5] U.S
CrossRef Laursen TM, Musliner KL, Benros ME, et al
